You are required to be logged in to access the full website
Click here if you have forgotten your username or password
22 September 2026 - Clene Inc (Nasdaq:CLNN), a clinical-stage biotechnology company focused on amyotrophic lateral sclerosis (ALS), announced on Monday the closing of a registered direct offering of common stock to existing shareholders, including in...
22 September 2026 - US pharmaceutical company AbbVie (NYSE:ABBV), and Iambic, a clinical-stage life sciences and technology company developing novel medicines through its AI-driven discovery and development platform, announced on Monday a multi-year ...
22 September 2026 - Beacon Therapeutics, a clinical-stage biotechnology company focused on ocular diseases, on Monday reported positive topline results for its registration-enabling VISTA trial evaluating laruparetigene zovaparvovec (laru-zova) in pa...
22 September 2026 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) on Monday published an update on its share buy-back programme launched on 1 September 2026, under which the company will repurchase shares for an amount up to DKK250m i...
22 September 2026 - Grunenthal, a German pharmaceutical company focused on pain management and related diseases, announced on Monday that it has entered into an agreement with German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:B...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe